Abstract

MESSOUNA Mohamed*, MOSSE Wilfred, NDA Guy, LKHOYALI Siham, ICHOU Mohamed and ERRIHANI Hassan

ABSTRACT

Hodgkin lymphoma is cancer mainly affecting B lymphocytes.[1] In Morocco, it accounts for 1.6% of cases recorded during the period 2008 to 2012.[2] The cure rate has increased significantly in recent decades due to a combination of chemotherapy and radiation therapy.[1,3, 3] It is estimated that more than 80% of cases are curable[curable.[1,3,4,3,4] This increase in survival rates is the result of more effective treatments. However, their toxicities remain significant. In our study, we found 49% neutropenia, 26% anaemia, 26% thrombopenia, 35% nausea and vomiting, 32% diarrhea, 9.4% mucite, 39% peripheral neuropathy, 36% alopecia, 29% skin colour, 49.2% pain, 20.2% asthenia and anorexia, 32% diarrhea. There were more neutropenia and peripheral neuropathy in patients treated with BEACOPP ESCALADE, 53.8% vs. 46.8% and 50% vs. 32%, respectively. On the other hand, we found more digestive toxicities (nausea and vomiting, diarrhea) in patients treated with ABVD, respectively 38.5% versus 29% and 37.5% versus 23%).[3,4,5] Grade I and II toxicities did not require discontinuation of treatment or postponement of chemotherapy and were treated as an outpatient, while grades III and IV were hospitalized with clinical and para-clinical examinations.